Literature DB >> 7772105

Lack of association between cholesterol and coronary heart disease mortality and morbidity and all-cause mortality in persons older than 70 years.

H M Krumholz1, T E Seeman, S S Merrill, C F Mendes de Leon, V Vaccarino, D I Silverman, R Tsukahara, A M Ostfeld, L F Berkman.   

Abstract

OBJECTIVES: To determine whether elevated serum cholesterol level is associated with all-cause mortality, mortality from coronary heart disease, or hospitalization for acute myocardial infarction and unstable angina in persons older than 70 years. Also, to evaluate the association between low levels of high-density lipoprotein cholesterol (HDL-C) and elevated ratio of serum cholesterol to HDL-C with these outcomes.
DESIGN: Prospective, community-based cohort study with yearly interviews. PARTICIPANTS: A total of 997 subjects who were interviewed in 1988 as part of the New Haven, Conn, cohort of the Established Population for the Epidemiologic Study of the Elderly (EPESE) and consented to have blood drawn. MAIN OUTCOME MEASURES: The risk factor-adjusted odds ratios of the 4-year incidence of all-cause mortality, mortality from coronary heart disease, and hospitalization for myocardial infarction or unstable angina were calculated for the following: subjects with total serum cholesterol levels greater than or equal to 6.20 mmol/L (> or = 240 mg/dL) compared with subjects with cholesterol levels less than 5.20 mmol/L (< 200 mg/dL); subjects in the lowest tertile of HDL-C level compared with those in the highest tertile; and subjects in the highest tertile of the ratio of total serum cholesterol to HDL-C level compared with those in the lowest tertile.
RESULTS: Elevated total serum cholesterol level, low HDL-C, and high total serum cholesterol to HDL-C ratio were not associated with a significantly higher rate of all-cause mortality, coronary heart disease mortality, or hospitalization for myocardial infarction or unstable angina after adjustment for cardiovascular risk factors. The risk factor-adjusted odds ratio for all-cause mortality was 0.99 (95% confidence interval [CI], 0.56 to 2.69) for the group who had cholesterol levels greater than or equal to 6.20 mmol/L (> or = 240 mg/dL) compared with the group that had levels less than 5.20 mmol/L (< 200 mg/dL); 1.00 (95% CI, 0.59 to 1.70) for the group in the lowest tertile of HDL-C compared with those in the highest tertile; and 1.03 (95% CK, 0.62 to 1.71) for subjects in the highest tertile of the ratio of total serum cholesterol to HDL-C compared with those in the lowest tertile.
CONCLUSIONS: Our findings do not support the hypothesis that hypercholesterolemia or low HDL-C are important risk factors for all-cause mortality, coronary heart disease mortality, or hospitalization for myocardial infarction or unstable angina in this cohort of persons older than 70 years.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7772105

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  75 in total

Review 1.  Strength training in the elderly: effects on risk factors for age-related diseases.

Authors:  B F Hurley; S M Roth
Journal:  Sports Med       Date:  2000-10       Impact factor: 11.136

Review 2.  The relationship between cholesterol and stroke: implications for antihyperlipidaemic therapy in older patients.

Authors:  C Sarti; M Kaarisalo; J Tuomilehto
Journal:  Drugs Aging       Date:  2000-07       Impact factor: 3.923

3.  The cost of inadequate prescriptions for hypolipidaemic drugs. VICAF Group.

Authors:  L C Ballesteros; M I Fernández San Martín; T Sanz Cuesta; E Escortell Mayor; C López Bilbao
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

4.  Cardiovascular disease: risk factors in older Canadians.

Authors:  D R MacLean
Journal:  CMAJ       Date:  1999       Impact factor: 8.262

Review 5.  Initiation of statin therapy: are there age limits?

Authors:  Dipan A Desai; Sammy Zakaria; Pamela Ouyang
Journal:  Curr Atheroscler Rep       Date:  2012-02       Impact factor: 5.113

6.  Undertreatment of hyperlipidemia in the secondary prevention of coronary artery disease.

Authors:  S R Majumdar; J H Gurwitz; S B Soumerai
Journal:  J Gen Intern Med       Date:  1999-12       Impact factor: 5.128

7.  Elevated high-sensitivity C-reactive protein as a risk marker of the attenuated relationship between serum cholesterol and cardiovascular events at older age. The ARIC Study.

Authors:  Seamus P Whelton; Probal Roy; Brad C Astor; Lin Zhang; Ron C Hoogeveen; Christie M Ballantyne; Josef Coresh
Journal:  Am J Epidemiol       Date:  2013-09-10       Impact factor: 4.897

Review 8.  Statin therapy in the elderly: does it make good clinical and economic sense?

Authors:  Moira M B Mungall; Allan Gaw; James Shepherd
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

9.  Troponin T, NT-proBNP, and venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE).

Authors:  Aaron R Folsom; Pamela L Lutsey; Vijay Nambi; Christopher R deFilippi; Susan R Heckbert; Mary Cushman; Christie M Ballantyne
Journal:  Vasc Med       Date:  2014-02       Impact factor: 3.239

10.  Improving global vascular risk prediction with behavioral and anthropometric factors. The multiethnic NOMAS (Northern Manhattan Cohort Study).

Authors:  Ralph L Sacco; Minesh Khatri; Tatjana Rundek; Qiang Xu; Hannah Gardener; Bernadette Boden-Albala; Marco R Di Tullio; Shunichi Homma; Mitchell S V Elkind; Myunghee C Paik
Journal:  J Am Coll Cardiol       Date:  2009-12-08       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.